EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Delayed gametocyte clearance in Plasmodium vivax malaria is associated with polymorphisms in the cytochrome P450 reductase (CPR)

Yanka Evellyn Alves Rodrigues Salazar iD, Jaime Louzada, Maria Carolina Silva de Barros Puça iD, Luiz Felipe Ferreira Guimarães, José Luiz Fernandes Vieira, André Machado de Siqueira, José Pedro Gil, Cristiana Ferreira Alves de Brito, Tais Nobrega de Sousa iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.01204-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Yanka Evellyn Alves Rodrigues Salazar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology and Malaria Immunology Research Group, Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Vivax, Malaria, Falciparum, Artemisinins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Vetenskapsrådet (VR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primaquine (PQ) is the main drug used to eliminate dormant liver stages and prevent relapses in Plasmodium vivax malaria. It also has an effect on the gametocytes of Plasmodium falciparum ; however, it is unclear to what extent PQ affects P. vivax gametocytes. PQ metabolism involves multiple enzymes, including the highly polymorphic CYP2D6 and the cytochrome P450 reductase (CPR). Since genetic variability can impact drug metabolism, we conducted an evaluation of the effect of CYP2D6 and CPR variants on PQ gametocytocidal activity in 100 subjects with P. vivax malaria. To determine gametocyte density, we measured the levels of pvs25 transcripts in samples taken before treatment (D0) and 72 hours after treatment (D3). Generalized estimating equations (GEEs) were used to examine the effects of enzyme variants on gametocyte densities, adjusting for potential confounding factors. Linear regression models were adjusted to explore the predictors of PQ blood levels measured on D3. Individuals with the CPR mutation showed a smaller decrease in gametocyte transcript levels on D3 compared to those without the mutation ( P = 0.02, by GEE). Consistent with this, higher PQ blood levels on D3 were associated with a lower reduction in pvs25 transcripts. Based on our findings, the CPR variant plays a role in the persistence of gametocyte density in P. vivax malaria. Conceptually, our work points to pharmacogenetics as a non-negligible factor to define potential host reservoirs with the propensity to contribute to transmission in the first days of CQ–PQ treatment, particularly in settings and seasons of high Anopheles human-biting rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMalaria, VivaxMalaria, FalciparumArtemisininsMalariaHumansNADPH-Ferrihemoprotein ReductaseChloroquineCytochrome P-450 CYP2D6PrimaquinePlasmodium falciparumPlasmodium vivax

Stichwörter der Autor:innen

CYP2D6Plasmodium vivaxcytochrome P450 reductasegametocytesmalariapharmacogeneticsprimaquine

Substanzen

AntimalarialsNADPH-Ferrihemoprotein ReductaseChloroquineCytochrome P-450 CYP2D6ArtemisininsPrimaquine

Autor:innen und Institutionen

  • Molecular Biology and Malaria Immunology Research Group, Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ), Belo Horizonte, Minas Gerais, Brazil.
  • Universidade Federal de Roraima, Boa Vista, Roraima, Brazil.
  • Universidade Federal do Pará, Belém, Pará, Brazil.
  • Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Rio de Janeiro, Brazil.
  • Department of Microbiology, Tumor and Cell biology, Karolinska Institutet, Solna, Sweden.

ORCID-Profile: Yanka Evellyn Alves Rodrigues Salazar, Maria Carolina Silva de Barros Puça, Tais Nobrega de Sousa

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Vetenskapsrådet (VR)
  • Bill and Melinda Gates Foundation (GF)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Zitieren

APA

Salazar, Y. E. A. R., Louzada, J., Puça, M. C. S. B., Guimarães, L. F. F., Vieira, J. L. F., Siqueira, A. M., Gil, J. P., Brito, C. F. A., & Sousa, T. N. (2024). Delayed gametocyte clearance in Plasmodium vivax malaria is associated with polymorphisms in the cytochrome P450 reductase (CPR). Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01204-23

Vancouver

Salazar YEAR, Louzada J, Puça MCSB, Guimarães LFF, Vieira JLF, Siqueira AM, et al. Delayed gametocyte clearance in Plasmodium vivax malaria is associated with polymorphisms in the cytochrome P450 reductase (CPR). Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.01204-23

BibTeX
@article{Salazar2024,
  author = {Salazar, Yanka Evellyn Alves Rodrigues and Louzada, Jaime and Puça, Maria Carolina Silva de Barros and Guimarães, Luiz Felipe Ferreira and Vieira, José Luiz Fernandes and Siqueira, André Machado de and Gil, José Pedro and Brito, Cristiana Ferreira Alves de and Sousa, Tais Nobrega de},
  title = {Delayed gametocyte clearance in Plasmodium vivax malaria is associated with polymorphisms in the cytochrome P450 reductase (CPR)},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.01204-23}
}
Kostenlos starten →